BRIEF—Bionure Farma appoints new CEO

Bionure Farma, a spin-off from the Hospital Clinic of Barcelona, has appointed Laurent Nguyen as the new chief executive officer.

Dr Nguyen held roles at Hoechst-Roussel, Merck Group, Roche and Pierre Fabre, before leading a French academic spin-off that he later took public.

Bionure is developing the neuroprotectant BN201, a small molecule currently in a clinical Phase I study in the UK, with results expected at the beginning of 2019.